Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Deccan Health Care's Enterprise Value is ₹341.8 Mil.
Deccan Health Care's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.0 Mil. Therefore, Deccan Health Care's EV-to-FCF for today is .
The historical rank and industry rank for Deccan Health Care's EV-to-FCF or its related term are showing as below:
BOM:542248'
s EV-to-FCF Range Over the Past 10 Years
Min: -5.23 Med: 46.69 Max: 214.2
Current: -5.23
During the past 11 years, the highest EV-to-FCF of Deccan Health Care was 214.20. The lowest was -5.23. And the median was 46.69.
BOM:542248's EV-to-FCF is ranked worse than 100% of 569
companies
in the Drug Manufacturers industry
Industry Median: 21.24
vs BOM:542248: -5.23
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Deccan Health Care (BOM:542248) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Deccan Health Care's PE Ratio (TTM) for today is calculated as:
Deccan Health Care's share price for today is ₹13.20.
Deccan Health Care's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1.020.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Deccan Health Care EV-to-FCF Related Terms
Deccan Health Care EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Deccan Health Care's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Deccan Health Care's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Deccan Health Care EV-to-FCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Deccan Health Care's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Deccan Health Care's EV-to-FCF falls into.
Deccan Health Care's current Enterprise Value is ₹341.8 Mil.
Deccan Health Care's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Is Deccan Health Care (BOM:542248) Overvalued in 2026?
Based on GuruFocus' analysis, Deccan Health Care stock appears to be undervalued.
The current stock price of ₹13.20 is trading 49.5% below its estimated GF Value™ of ₹26.16.
GuruFocus considers Deccan Health Care to be Significantly Undervalued.
Key valuation signals for BOM:542248:
EV-to-FCF:
GF Value™: ₹26.16 vs. price of ₹13.20 (49.5% below fair value)
No single metric tells the full story. See the BOM:542248 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Deccan Health Care Ltd is into developing, manufacturing, and marketing a broad range of healthcare products, including nutraceutical, cosmeceutical, and ayurveda products (Fast Moving Consumer Health Products). Its products are Nutraceutical Food Products and other supplements and medicines. The company is operating in a single segment of manufacturing of nutraceutical products. The company operates in India as well as exports its products to other countries, and the majority of its revenue comes from India.
77GF Score
Get the complete analysis for BOM:542248
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:542248 has been successfully added to your 
